Suchen
Brainsway Ltd
BWAYZur Watchlist hinzufügen
15.190USD
-0.100-0.65%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
594.93MMarktkapitalisierung
33.12KGV TTM
mehr Informationen über Brainsway Ltd Unternehmen
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Brainsway Ltd Informationen
BörsenkürzelBWAY
Name des UnternehmensBrainsway Ltd
IPO-datumDec 24, 2006
CEOLevy (Hadar)
Anzahl der mitarbeiter120
WertpapierartDepository Receipt
GeschäftsjahresendeDec 24
Addresse16 Hartum Street Rad Tower, 14Th Floor
StadtJERUSALEM
BörseNASDAQ OMX - NASDAQ BASIC
LandIsrael
Postleitzahl9777516
Telefon97225813140
Websitehttps://www.brainsway.com/
BörsenkürzelBWAY
IPO-datumDec 24, 2006
CEOLevy (Hadar)
Führungskräfte von Brainsway Ltd
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Dr. Yiftach Roth
Dr. Yiftach Roth
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Avner Hagai
Mr. Avner Hagai
Independent Director
Independent Director
--
--
Ms. Eti Michal Mitrany Rayten
Ms. Eti Michal Mitrany Rayten
Independent Director
Independent Director
--
--
Ms. Karen Sarid
Ms. Karen Sarid
Independent Director
Independent Director
--
--
Mr. Yosef (Yossi) Ben Shalom
Mr. Yosef (Yossi) Ben Shalom
Independent Director
Independent Director
--
--
Prof. Abraham Zangen, Ph.D.
Prof. Abraham Zangen, Ph.D.
Director
Director
--
--
Mr. Hadar Levy
Mr. Hadar Levy
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Avner Lushi
Mr. Avner Lushi
Independent Director
Independent Director
--
--
Mr. Christopher Boyer
Mr. Christopher Boyer
Vice President - Global Marketing
Vice President - Global Marketing
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. David Zacut, M.D.
Dr. David Zacut, M.D.
Vice Chairman of the Board
Vice Chairman of the Board
--
--
Dr. Yiftach Roth
Dr. Yiftach Roth
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Avner Hagai
Mr. Avner Hagai
Independent Director
Independent Director
--
--
Ms. Eti Michal Mitrany Rayten
Ms. Eti Michal Mitrany Rayten
Independent Director
Independent Director
--
--
Ms. Karen Sarid
Ms. Karen Sarid
Independent Director
Independent Director
--
--
Mr. Yosef (Yossi) Ben Shalom
Mr. Yosef (Yossi) Ben Shalom
Independent Director
Independent Director
--
--
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von Brainsway Ltd?
Die fünf größten Anteilseigner von Brainsway Ltd sind: Dr. David Zacut, M.D.
Wie viele Institutionen halten Anteile an Brainsway Ltd (BWAY)?
Mit Stand vom 2026Q1 halten 95 Institutionen Anteile an Brainsway Ltd, mit einem Gesamtmarktwert von etwa 12.27M, was 30.66% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -3188785.00 gestiegen.